BioHealth News
Altimmune to Host Virtual R&D Day on March 13, 2025
GAITHERSBURG, M.D., March 06, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will host a virtual R&D…
Read MoreWBJ: New York health-tech company Claritev moves headquarters to Northern Virginia
By Sara Gilgore – Staff Reporter, Washington Business Journal -Mar 5, 2025 - A New York health care technology company that recently adopted a…
Read MoreQIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio
GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)-- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared…
Read MoreAscentage Pharma’s Olverembatinib Granted Breakthrough Therapy Designation for Ph+ Acute Lymphoblastic Leukemia (ALL)
ROCKVILLE, Md. and SUZHOU, China, March 05, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering,…
Read MoreUSP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients
USP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients Rockville, MD – The U.S. Pharmacopeia (USP)…
Read MoreTEDCO Invests in Irazú Oncology
Life sciences company developing a cost-effective production process for cancer immunotherapies COLUMBIA, Md., (March 5, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a…
Read MoreREGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS Diseases
ROCKVILLE, Md., March 4, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the closing of its previously announced strategic partnership with Nippon Shinyaku. Under the terms of the…
Read MoreIGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer’s and Dementia Detection
POTOMAC, MD / ACCESS Newswire / March 4, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced an advancement in its Artificial Intelligence…
Read MoreGeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today an indication expansion for its industry leading…
Read MoreVenture Valkyrie: Tough Love for Women’s Health Entrepreneurs Raising Venture Money
Since I have been raising and deploying a venture fund focused on addressing health of women lately, I have had numerous occasions to be in rooms…
Read MoreBioBuzz: TEDCO’s Impact on Maryland’s Entrepreneurial Ecosystem
By Annabel Baldy - In November’s What’s the Buzz?! LinkedIn Live session, Chris Frew, CEO of BioBuzz and Tammi Thomas, Chief Development & Marketing Officer, TEDCO…
Read MoreGEN: Former NIH Director Francis Collins Praises the Institution as He Abruptly Departs After Three Decades
By Kevin Davies, PhD - March 3, 2025 - After an illustrious career including 12 years as director of the National Institutes of Health…
Read MoreGEN: FDA Accepts for Review Precigen RRP Gene Therapy Candidate
By Alex Philippidis - February 26, 2025 - The FDA has granted Priority Review to Precigen’s Biologics License Application (BLA) for its lead candidate…
Read MoreTNF Pharmaceuticals Launches Phase 2b Trial for First Oral TNF-Alpha Inhibitor to Combat Muscle Loss and Frailty
BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory…
Read MoreCityBiz – Protenus: From Accelerator to Acquisition
Protenus, a leading healthcare compliance analytics platform that serves over 200 healthcare organizations, was acquired in January 2025 by Bluesight, a prominent provider of inventory management, procurement,…
Read More